Clinical Trial Update: Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating low-dose cytarabine (Cytosar) in combination with arsenic trioxide for elderly patients with non-promyelocytic acute myeloid l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)
• Cytosar (cytarabine)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Leukemia, Myeloid, Acute | Phase 2 | Status: COMPLETED